Aldactone at a Glance
Aldactone 25 mg is a pharmaceutical-grade spironolactone formulation manufactured by RPG Life Sciences Ltd. This compound represents a potassium-sparing diuretic agent extensively studied in cardiovascular and renal research applications. Each tablet contains 25 mg of spironolactone, providing researchers with standardised dosing for in-vitro experimental protocols. The pharmaceutical presentation ensures consistent quality and purity standards essential for reproducible laboratory investigations. Researchers at Stroid UK Shop benefit from accessing this established compound through our verified supply chain, supporting diverse research objectives in metabolic and cardiovascular studies.
Laboratory Applications
Spironolactone demonstrates significant research value in mineralocorticoid receptor antagonism studies. Investigators examine its aldosterone-blocking properties in cell culture models, particularly focusing on sodium-potassium exchange mechanisms. The compound’s anti-androgenic properties provide additional research opportunities in hormonal pathway investigations. Laboratory studies frequently evaluate spironolactone’s effects on electrolyte transport systems and renal function models. Researchers investigating cardiovascular pathophysiology utilise this compound to examine heart failure mechanisms and fluid retention processes. The pharmaceutical formulation enables precise experimental control in dose-response studies. Advanced research applications include examining diuretic mechanisms alongside complementary compounds available through our extensive catalogue, including specialised selective androgen receptor modulators and research peptides for comprehensive hormonal pathway investigations.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Spironolactone |
| Strength | 25 mg per tablet |
| Manufacturer | RPG Life Sciences Ltd. |
| Form | Oral tablets |
| CAS Number | 52-01-7 |
| Molecular Formula | C₂₄H₃₂O₄S |
| Molecular Weight | 416.57 g/mol |
| Storage | Room temperature, dry conditions |
Research Compliance
This pharmaceutical preparation is supplied exclusively for in-vitro laboratory research applications. Aldactone 25 mg tablets are intended for qualified researchers conducting approved scientific investigations into mineralocorticoid receptor mechanisms, diuretic pathways, and related cardiovascular research protocols. The compound must be handled according to laboratory safety guidelines and stored under appropriate conditions to maintain stability. Researchers should verify compatibility with their experimental protocols and institutional review requirements before procurement. All investigations must comply with relevant research ethics frameworks and institutional guidelines for pharmaceutical research compounds.
Important: This product is for laboratory research use only. Not intended for human consumption, therapeutic use, or any application outside controlled research environments.
